Francisco J. López

Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration

David Callanan, Derek Kunimoto, Raj K. Maturi et al. · Journal of Ocular Pharmacology and Therapeutics · 2018 · 74 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17

A Possible Dual Mechanism of the Anovulatory Action of Antiprogesterone RU486 in the Rat1

José E. Sánchez‐Criado, C. Bernal Bellido, Francisco Galiot et al. · Biology of Reproduction · 1990 · 72 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Treatment with selective estrogen receptor modulators regulates myelin specific T‐cells and suppresses experimental autoimmune encephalomyelitis

Bruce F. Bebo, Babak Dehghani, Scott Foster et al. · Glia · 2008 · 71 citations

Life Sciences, Immunology, Neuroscience +17

Lipoprotein-associated phospholipase A ₂ (Lp-PLA ₂ ) as a therapeutic target to prevent retinal vasopermeability during diabetes

Paul Canning, Bridget-Ann Kenny, Vivien E. Prise et al. · Proceedings of the National Academy of Sciences · 2016 · 68 citations · Full text

Medicine, Ophthalmology, Pharmacology +16

PHASE 2 STUDY OF THE SAFETY AND EFFICACY OF BRIMONIDINE DRUG DELIVERY SYSTEM (BRIMO DDS) GENERATION 1 IN PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION

Baruch D. Kuppermann, Sunil Patel, David S. Boyer et al. · Retina · 2020 · 66 citations · Full text

Pharmacy, Ophthalmology, Pharmacotherapy +17